Stockholders' Deficit

3 Months Ended

Mar. 31, 2017

Stockholders' Deficit [Abstract]

STOCKHOLDERS' DEFICIT

NOTE 8 – STOCKHOLDERS’ DEFICIT

COMMON STOCK

During the quarter ended March 31, 2017, the Company sold 13,800,000 restricted shares of common stock at $0.01 per share for total proceeds of $138,000.

During the quarter ended March 31, 2017, the Company granted 568,616 restricted shares of common stock for business development services. The Company valued the shares based on the closing price of the Company common stock on those days during which such services were performed. This resulted in $11,875 of expense for the quarter ended March 31, 2017.

COMMON STOCK WARRANTS

The Company did not issue warrants for the three months ended March 31, 2017 and 2016 and no warrants were exercised. Ten warrants, exercisable in the aggregate for a total of 2,900,000 shares of common stock, expired prior to exercise during the three months ended March 31, 2016. As of March 31, 2017, there were no warrants outstanding.